StockData
Altimmune, Inc. logo

Altimmune, Inc. (ALT) stock

ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$1.53−0.03 (-1.92%)

Close on Nov 17, 2026Market cap $297.61MP/E –Yield –

Altimmune market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Altimmune's market cap was $375.34M on Nov 11, 2026, against $502.85M a year earlier. Over the last 5 years it ranged from $126.90M to $1.02B, with a median of $422.59M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$375.34M+8.8%
2025Dec 31, 2025$345.11M-32.7%
2024Dec 31, 2024$512.81M-13.8%
2023Dec 29, 2023$594.66M-26.5%
2022Dec 30, 2022$808.71M+122.4%
2021Dec 31, 2021$363.68M-2.5%
2020Dec 31, 2020$373.06M+1186.9%
2019Dec 31, 2019$28.99M+715.5%
2018Dec 31, 2018$3.55M-88.6%
2017Dec 29, 2017$31.10M-86.6%
2016Dec 30, 2016$231.32M-36.4%
2015Feb 20, 2015$363.49M+31.4%
2013May 28, 2013$276.70M+5.5%
2012Dec 31, 2012$262.36M+4.2%
2011Dec 30, 2011$251.73M–

More Altimmune figures

See a number that looks wrong?